Many people view tumors as a homogenious mass of malignant cells that have hijacked our body's normal status to grow unchecked by our immune system. In reality, tumors are an integrated system of interacting cell types, including malignant tum...
Read more
Cancer diagnostics company Cernostics announced collaboration with the Academic Medical Center in The Netherlands, which will give the Oakland company access to one of the world's biggest Barrett's Esophagus patient registries in the world....
Read more
A few quick questions with Mike Hoerres, CEO of Cernostics: Q: When did you first become interested in molecular diagnostics? A: During high school (in Wisconsin) I was captivated by the idea that we can harness bacteria to become factories fo...
Read more
Cernostics, a diagnostics company focused on delivering next generation cancer diagnostics through a unique approach to tissue analysis, announced today that it is collaborating with the Academic Medical Center in The Netherlands (AMC). As part of t...
Read more
Cernostics said on Tuesday it is collaborating with the Academic Medical Center in the Netherlands to complete validation studies of the company's test for cancer in patients with Barrett's Esophagus....
Read more
Cernostics, a diagnostics company focused on delivering next generation cancer diagnostics through a unique approach to tissue analysis, announced today that it is collaborating with the Academic Medical Center in The Netherlands (AMC). As part of t...
Read more
